Clinical trial
Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart…
NCT00400985 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00400985 |
|---|---|
| Title | Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure |
| Official title | Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure |
| Acronym | SENSE-HF |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Device |
| Interventions | Implantable device: monitoring of intrathoracic impedance using the OptiVol diagnostic tool. |
| Enrollment | 501 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Nov 17, 2006 |
| Last update posted | Jul 2, 2025 |
| Countries | Belgium, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: